Loading…
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Tender Value
Refer Docs
Closing Date
28 Jan 2026, 11:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Single Packet
Normal Tender
No
Itemwise/Consigneewise
Lowest to Highest
CONSIGNEE
Rly. Board
Expenditure
General
82
2 conditions
Procurement will be done from firms: - (A) Firms which are registered with the Railway Board at the time of tender opening date for the tendered item in their approved list. The product supplied must be manufactured at a unit inspected by Indian Railways and the name of the manufacturer must be disclosed by the bidder in their e-offer (for products manufacturing outside India, inspection of manufacturing unit is not required). OR (B) Firms which are registered with the Railway Board at the time of tender opening date and having average last three years turnover of more than 1000 Crores will be eligible for bulk order. The product supplied must be manufactured at a unit inspected by Indian Railways and the name of the manufacturer must be disclosed by the bidder in their e-offer (for products manufacturing outside India, inspection of manufacturing unit is not required). OR (C) Firms meeting the following conditions:- (i) Valid License to manufacture the drug. and (ii) Valid GMP Certificate and (iii) Five years market standing/manufacturing certificate by Drug Authority. In this regard, the firm must attach the relevant documents along with their offer. Failure to do so will result in the immediate rejection of the offer
In keeping with the Public Procurement (Preference to Make in India) Order, 2017, as amended, and in terms of clause 2.4.2, 2.4.5 and 2.4.6 of Instructions to Tenderers Rev. 1.21 April 2024 (along with all its correction slips, if any), Public procurement of this item is restricted to Class - I and Class-II local suppliers only. Thus, only class-I and class-II local supplier as defined under the public procurement (Preference to Make in India) Order, 2017, as amended shall be eligible to bid in this tender. Offer from vendors who do not quality to be Class - I (Local Content: minimum 50%) or Class-II (Local Content: minimum 20% but less than 50%) local supplier, shall be summarily rejected and, therefore, such vendors should not participate in the tender. In case any vendor who does not qualify to be a Class - I or Class-II local supplier for the tendered item participates in the tender, such a bidder does so at its own risk and cost and Railways shall not be liable for any loss or damage caused to the bidder on this account. NOTE -: As per Public Procurement (Preference to Make in India) Order, 2017, procurement where the estimated value to be procured is less than Rs 5 lakhs shall be exempt from this Order.
20 conditions · 1 needing a document upload
Entities of countries which have been identified by nodal Ministry/Department as not allowing Indian companies to participate in their Government procurement for any item related to that Ministry/Department shall not be allowed to participate in Government procurement in India for all items related to that nodal Ministry/Department, except for the list of items published by the Ministry/Department permitting their participation. The terms entity of a country shall have the same meaning as in the FDI policy of DPIIT as amended from time to time.
Firm is required to give complete details of distributor including bank details along with the contact person and contact number, if supply is to be made through Distributor.
Firm must mention the name(s) of specific stores of area where such drug is being sold in the open retail market by same brand name.
Firm should mention the detailed address of the manufacturing unit of the tendered item(s) and enclose copy of the valid approved list of Railway Board showing the manufacturing unit.
In terms of clause as per Para 2.4.3 of Instruction to Tenderers regarding restrictions on procurement form a bidder of a country which shares a land border with India. I, hereby confirm that I have read the clause regarding restrictions on procurement form a bidder of a country which shares a land border with India and I certify that I am not from such a country.
Please enter the percentage of local content in the material being offered. Please enter 0 for fully imported items, and 100 for fully indigenous items. The definition and calculation of local content shall be in accordance with the Make in India policy as incorporated in the tender conditions.
2 locations across Delhi, Uttar Pradesh · 7,100 Numbers total
(Clubbed Item) (AMI NO .9.0) & (AMI No. 8.358) (2025-26) Collagen Peptides 10gm, Glucosamine 1500mg and Ascorbic Acid / Vitamin C 35mg ( Kondroflex Sachet or Equivalent)
82252181E~NR
82252181E
Limited - Indigenous
Goods
North Delhi, Delhi
₹0
Exempted
28 Jan 2026
21 Jan 2026
2 items · 7,100 Numbers total
(AMI No. 8.358) (2025-26) Collagen Peptides 10gm, Glucosamine 1500mg and Ascorbic Acid / Vitamin C 35mg ( Kondroflex Sachet or Equivalent) ]
| Delivery Location | State | Quantity |
|---|---|---|
| NR Divisional Hospital Delhi, NR | Delhi | 2100.00 Numbers |
| Total | 2,100 Numbers | |
(AMI N. 9.0) (2025-26) Collagen Peptides 10gm, Glucosamine 1500mg and Ascorbic Acid / Vitamin C 35mg ]
| Delivery Location | State | Quantity |
|---|---|---|
| NR Divisional Hospital Moradab, NR | Uttar Pradesh | 5000.00 Numbers |
| Total | 5,000 Numbers | |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
HTML
nit.pdf
NIT
5248352.pdf
ATTACHMENT
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .